Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

The full indication for vilobelimab is as a treatment for adult patients with SARS‑CoV-2‑induced ARDS who are receiving ...

The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.

Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...

Increased exposure to fine particulate matter during pregnancy significantly increased the likelihood of having a spontaneous ...

Evidence-based smoking cessation treatment within 6 months of a cancer diagnosis yielded the largest survival benefit, ...

Parents often worry that their child is a poor eater, so health professionals need to know what's normal and when ...

For decades, no-show patients have proven to be a costly problem for physicians. In fact, missed appointments lead to a ...

Women with PCOS have longer interconception periods, are of advanced maternal age, and have higher nulliparity and lower ...

Socioeconomic and educational disparities significantly affect the access of women to cancer screening and care in Europe.

Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...